Semaglutide Weight Loss Timeline: What Trial Data Shows
There is no evidence-based month-by-month weight-loss curve that predicts an individual's semaglutide result. Product labels provide formulation-specific dose schedules, and trials provide group averages at defined study time points. Neither supports promises about how many pounds a person should lose in month one, three, or six.
The Best-Known Trial Result
In STEP 1, adults with overweight or obesity without diabetes were randomized to once-weekly subcutaneous semaglutide 2.4 mg or placebo, both with lifestyle intervention. At 68 weeks, the estimated mean change in body weight was -14.9% with semaglutide and -2.4% with placebo.
That statement keeps the medication, dose, population, comparator, co-intervention, duration, and result together. It does not mean every participant lost 14.9%, that the change occurred evenly each month, or that someone using a different semaglutide product should expect the same outcome.
Titration Is a Dose Schedule, Not a Results Calendar
The current Wegovy prescribing information contains formulation-specific initiation, escalation, maintenance, and missed-dose instructions. The current label includes more than one formulation, so older articles that describe only one weekly injection ladder may be incomplete.
The current Ozempic prescribing information has a different indication and dose schedule. Ozempic and Wegovy contain semaglutide but are not interchangeable, and their milligram instructions should not be blended into one “semaglutide timeline.”
A dose-change date on a chart records sequence. It does not prove that a later weight change was caused by the dose or that the next increase will accelerate loss.
Why Personal Curves Differ
Trial averages include a range of individual responses. A personal record may be influenced by the treated condition, formulation, prescribed dose, adherence, adverse reactions, illness, other medicines, measurement conditions, and many other factors.
That variation is why these common claims should be avoided:
- “You should lose a fixed percentage by month three.”
- “Weight loss always accelerates after a specific dose.”
- “A flat trend for a set number of weeks proves a plateau.”
- “A projected goal date becomes accurate after enough entries.”
- “A higher dose guarantees a larger result.”
How to Read Your Record
Use dated entries collected under reasonably consistent conditions when practical. A smoothed trend can summarize the direction of those entries, but it cannot distinguish fat, lean mass, and fluid.
Record medication and dose changes exactly as prescribed. Add relevant context such as illness, vomiting, diarrhea, constipation, travel, or another medication. Describe relationships cautiously: “the weight entries changed after the dose marker” is accurate; “the dose caused the change” is not established by the chart.
Bring a sustained or concerning change to your clinician. Do not increase, hold, stop, or restart semaglutide based on a curve or a comparison with someone else's timeline.
What About Plateaus?
There is no universal number of flat weeks that defines a plateau. Check measurement conditions and missing entries, then discuss the pattern with the prescriber. A flat line does not tell you whether the cause is medication, fluid balance, intake, illness, another medicine, or measurement variation.
The plateau review guide explains how to prepare that conversation without promising that a particular food, exercise routine, or dose increase will restart loss.
How OffGrid Dose Helps
OffGrid Dose places the weight and medication entries you provide on a timeline and can display dose-change markers. It is an organizational view, not a body-composition measurement, efficacy assessment, causal model, or dose recommendation.
The app stores its working data on your device. There is no OffGrid Dose account, company-operated cloud sync, or server-side health database, so OffGrid Dose does not receive your weight and medication history. Depending on your Apple and device settings, an encrypted device backup may include app data.
Frequently Asked Questions
How much weight should I lose in the first month?
STEP 1 does not establish a personal first-month target. Follow the exact prescription and discuss your response with the prescriber.
When does semaglutide start working?
The label and trial result do not provide a guaranteed point when an individual will feel or see a particular effect.
Does a higher dose mean faster weight loss?
Not necessarily. Dose decisions follow the exact product label and clinical judgment; a chart cannot promise a steeper trend.
Can I compare my curve with STEP 1?
Use STEP 1 as population-level context only if you keep its population, dose, comparator, lifestyle intervention, and 68-week duration attached.
This article is for informational purposes only and does not constitute medical advice. Follow the current label for the exact semaglutide product and discuss response or dose decisions with a qualified healthcare professional.
Related Articles
Track this with OffGrid Dose
Log every dose, rotate injection sites, and watch your weight trend in a private local working log.
Ozempic tracker →